Life Course Perspective on Alcohol and Drug Use Trajectories from Adolescence into Adulthood
Project Number5R01AA028812-04
Former Number1R01AA028812-01
Contact PI/Project LeaderD'AMICO, ELIZABETH J.
Awardee OrganizationRAND CORPORATION
Description
Abstract Text
Summary/Abstract
Young adulthood is a challenging time focused on making important decisions that can either facilitate or hinder
independence across a variety of domains. The CHOICE-STRATA Study (CHOICE STudy of Racial diversity in
AOD use during the Transition to Adulthood) has assessed alcohol and other drug (AOD) use and functioning in
numerous domains (e.g., social, economic, health) across 13 waves of data in youth from age 10 to age 24
(R01AA016577, R01AA020883, R01AA025848), with retention rates averaging 84% across the 12 waves
completed to date, and 91% from age 18 (waves 8-12). The proposed study, STRATA-XP (eXPanded), provides
an important opportunity to follow this large and racially/ethnically diverse cohort into young adulthood (ages
25-28), a unique developmental period for which there are few contemporary longitudinal studies of AOD use.
This application responds to NOT-AA-20-017: Epidemiology and Prevention in Alcohol Research, focused on
understanding the developmental trajectories of alcohol use, risky drinking, and alcohol use disorders and the
correlates of "maturing out" of heavy drinking. We propose to conduct 4 additional annual surveys from age 25-
28 (N=2,500) and address the following aims: Aim 1a: Identify trajectories of alcohol use (as well as tobacco,
cannabis, and other drug use) from age 10 into young adulthood. 1b.Examine effects of individual factors (e.g.,
resistance self-efficacy), peer factors (e.g., time spent around peers who use) and neighborhood factors (both
subjective and objective, including alcohol and cannabis outlet density) on AOD use trajectories. Aim 2:
Examine how AOD use trajectories across adolescence and emerging adulthood predict outcomes through age
28 in three core domains: 1) risk behaviors (e.g., AOD use and disorder, risky sexual behavior, delinquency), 2)
health-related quality of life (e.g., mental, physical, social), and 3) adult role functioning and transitions (e.g.,
employment, relationships and family formation, life satisfaction). Aim 3:Examine how adult role functioning
and transitions, such as pursuing a career and parenting, longitudinally predict subsequent changes in AOD use
and other risk behaviors, as well as health-related quality of life, in young adulthood. Aim 4: Provide an
understanding of potential across race/ethnicity, gender, and educational attainment that may occur across the
AOD trajectories and the factors associated with these trajectories. Continuing this work will move the field
forward by providing a better understanding of developmental patterns, antecedents, and consequences of AOD
use among today's young people as they transition into young adulthood.
Public Health Relevance Statement
Narrative
The current study continues to follow a cohort of youth who have been surveyed about their alcohol and other
drug (AOD) use since age 11, by having them complete four additional annual surveys from age 25-28. Continuing
this epidemiological work will move the field forward significantly by providing a unique opportunity to better
understand choices young people make around AOD use as they transition into young adulthood.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdolescenceAdultAdvertisingAffectAgeAge FactorsAlcohol consumptionAlcoholsAreaAsianAsian populationBlack raceCaliforniaCannabisCharacteristicsChild RearingDataDatabasesDevelopmentDiseaseDisparityDrug usageEconomicsEducationEmploymentEnvironmentEnvironmental Risk FactorEpidemiologyEthnic OriginExposure toFaceFamilyFemaleGenderGenerationsHealthHeavy DrinkingHispanicHispanic PopulationsIndividualInterventionKnowledgeLifeLife Cycle StagesLinkLongitudinal StudiesMeasuresMedical MarijuanaMental HealthNeighborhoodsPatternPersonsPlayPoliciesPositioning AttributePreventionPsyche structurePublic PolicyRaceResistanceRisk BehaviorsRisk FactorsRoleSamplingSelf EfficacyShapesSocial DevelopmentStructureStudentsSubgroupSurveysTimeTobaccoVocationWorkYouthage groupalcohol and other drugalcohol consequencesalcohol researchalcohol use disordercareercohortcollegedensitydriving under influenceemerging adulthoodethnic disparityethnic diversityfunctional independencehealth related quality of lifehigh risk drinkinghigh risk sexual behaviorjunior high schoolmisuse of prescription only drugsmulti-ethnicoutcome predictionpeerphysical conditioningprotective factorsracial disparityracial diversityrecruitretention ratesatisfactionschool districtsleep qualitysocialsocial mediasocial stressortransition to adulthooduniversity studentvaping nicotineyoung adult
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
273
DUNS Number
006914071
UEI
YY46Q97AEZA8
Project Start Date
01-August-2021
Project End Date
30-April-2026
Budget Start Date
01-May-2024
Budget End Date
30-April-2025
Project Funding Information for 2024
Total Funding
$596,389
Direct Costs
$429,459
Indirect Costs
$166,930
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Alcohol Abuse and Alcoholism
$596,389
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AA028812-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AA028812-04
Patents
No Patents information available for 5R01AA028812-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AA028812-04
Clinical Studies
No Clinical Studies information available for 5R01AA028812-04
News and More
Related News Releases
No news release information available for 5R01AA028812-04
History
No Historical information available for 5R01AA028812-04
Similar Projects
No Similar Projects information available for 5R01AA028812-04